From: A PK/PD model for the evaluation of clinical rifaximin dosage for the treatment of dairy cow mastitis induced by Escherichia coli
Parameters
AUC24/MIC
For2 log10 CFU/gland reduction
57.80
For2.5 log10 CFU/gland reduction
73.63
Log Emax (log10 CFU/gland)
2.36 ± 0.50
Log Emax-log E0 (log10 CFU/gland)
6.91 ± 0.63
EC50 (h)
38.85 ± 4.43
Slope (N)
1.35 ± 0.18